Cat#:RTS-031;Product Name:Influenza A+B Rapid Test Strip;Size:20T;Sample:Human nasopharyngeal specimens;Intended use:The Rapid Influenza A+B is a rapid chromatographic immunoassay for the qualitative detection of Influenza type A (including subtypes A/H1N1, A/H3N2, A/H5N1) and type B antigens in human nasopharyngeal specimens to aid in the diagnosis of Influenza infection. ;Description:Although a wide variety of viral agents are capable of causing lower respiratory tract infections in children and adults, Influenza A & B; respiratory syncytial virus (RSV); parainfluenza viruses 1, 2, and 3; and Adenovirus are the most common. Of these, Influenza A & B and RSV are the most important causes of medically attended acute respiratory illness. In addition to sharing a similar seasonal prevalence, it is important to remain cognizant that Influenza A & B and RSV share overlapping clinical features and infection potential for certain high-risk patient groups (e.g., extremes of age, underlying cardiopulmonary disease and immunosuppression). Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis.;Storage:Store at 15-25℃, DO NOT FREEZE or use beyond the expiration date. The shelf life is 21 months.;Detection Principle:The Rapid Influenza A+B is a qualitative lateral flow immunoassay for the detection of Influenza type A and type B antigens in human nasopharyngeal samples. The membrane is pre-coated with monoclonal antibodies against Influenza type A and type B antigens;Contents of Kit:1. Rapid Influenza A+B Card tests (Plastic pipettes included) 2. Instructions for use 3. Diluent (Sample diluent) 4. Swabs 5. Testing tubes or vials 6. Influenza A+B Control swabs;Sensitivity:>99%;References:BARENFANGER et al., “Clinical and Financial Benefits of Rapid Detection of Respiratory Viruses: an Outcomes Study”. Journal of Clinical Microbiology. August 2000, Vol 38 No 8, p. 2824-2828. ;